シアノコバラミンの世界市場 (投与経路別、最終用途別)：将来予測 (2025～2030年)

シアノコバラミン市場は、2023年に3億5,826万米ドルと評価され、2024年には3億7,929万米ドルに達すると予測され、CAGR 6.12%で成長し、2030年には5億4,313万米ドルに達すると予測されています。

シアノコバラミンはビタミンB12の合成型であり、DNA合成や赤血球形成など様々な代謝過程で重要な役割を果たしています。医薬品業界における主要なプレーヤーとして、その必要性は、特に菜食主義者、高齢者、吸収障害を持つ人々の間でビタミンB12欠乏症の有病率が増加していることに後押しされています。その用途は、栄養補助食品、栄養強化食品、貧血や神経障害の治療用の注射薬など多岐にわたる。最終用途の範囲は医療プロバイダー、製薬会社、飲食品業界にまで及ぶ。市場成長は、健康意識の高まりと栄養豊富な食事を優先する食事動向の影響を大きく受けています。さらに、高齢者人口の拡大や神経変性疾患に関する研究の活発化が需要を後押ししています。アジア太平洋とラテンアメリカの新興市場は、医療インフラの改善と栄養意識の高まりにより、有望な機会をもたらしています。しかし、市場の拡大は、特に注射剤に関する規制上のハードルや、天然由来または他の合成B12サプリメントとの競合といった課題に直面しています。原材料費による価格変動もリスクとなります。このような機会を生かすために、企業はバイオアベイラビリティの改善に重点を置いた研究に投資し、徐放性製剤や経口ストリップなど、消費者の利便性を高める新しい送達メカニズムを探求すべきです。持続可能でクリーンラベルの生産プロセスを重視することで、環境意識の高い消費者に対応し、ブランドのポジショニングを強化することができます。現在の市場競争は緩やかで、製品の差別化とイノベーションが特徴です。満たされていない消費者ニーズに戦略的に焦点を当て、バイオテクノロジーの進歩を活用することで、企業はさらなる成長を引き出すことができます。さらに、医療・プロバイダーと戦略的提携を結び、デジタル・プラットフォームを活用して消費者と直接関わることで、市場浸透を促進することができます。全体として、イノベーションの範囲は広大であり、消費者の嗜好や規制状況をよく理解し、この進化する市場をうまく乗り切ることが求められます。

市場力学：急速に進化するシアノコバラミン市場の主要市場インサイトを公開

シアノコバラミン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の高齢化人口の増加とビタミンB12欠乏症患者の増加
  • 世界の植物性食生活の普及
  • 機能性食品と栄養補助食品に対する需要の増加
• 市場抑制要因
  • ビタミンB12の天然・有機食品へのシフトに伴う厳しい認可基準
• 市場機会
  • 薬剤送達システムの技術進歩
  • 利点を付加した製剤の開発
• 市場の課題
  • 副作用や薬物との相互作用の可能性

ポーターのファイブフォース：シアノコバラミン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：シアノコバラミン市場における外部からの影響の把握

外部マクロ環境要因は、シアノコバラミン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：シアノコバラミン市場における競合情勢の把握

シアノコバラミン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：シアノコバラミン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、シアノコバラミン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：シアノコバラミン市場における成功への道筋を描く

シアノコバラミン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

当レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1. 市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2. 市場の発展度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3. 市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4. 競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5. 製品開発・イノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1. 現在の市場規模と今後の成長予測は？

2. 最高の投資機会を提供する製品、セグメント、地域はどこか？

3. 市場を形成する主な技術動向と規制の影響とは？

4. 主要ベンダーの市場シェアと競合ポジションは？

5. ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序論

第2章 分析手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化人口の増加とビタミンB12欠乏症の世界の増加
    • 世界中で植物由来の食事の採用が増加
    • 機能性食品や栄養補助食品の需要増加
  • 抑制要因
    • ビタミンB12の天然および有機食品源への移行に伴う承認の厳格な規制基準
  • 機会
    • 薬剤送達システムにおける技術的進歩
    • さらなるメリットをもたらす処方の開発
  • 課題
    • 潜在的な副作用と薬との相互作用
• 市場セグメンテーション分析
  • 投与経路：軽度のビタミンB12欠乏症患者に対するシアノコバラミンの経口製剤の好ましさが高まっている
  • 最終用途：ビタミンB12欠乏症の予防と治療のための医療分野でのシアノコバラミンの使用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的要因
  • 経済的要因
  • 社会的要因
  • 技術的要因
  • 法的要因
  • 環境的要因

第6章 シアノコバラミン市場：投与経路別

• 注入剤
• 経鼻剤
• 経口剤

第7章 シアノコバラミン市場：最終用途別

• 動物飼料
• 食品・飲料
• 医療

第8章 南北アメリカのシアノコバラミン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋のシアノコバラミン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのシアノコバラミン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析 (2023年)
• FPNVポジショニングマトリックス (2023年)
• 競合シナリオ分析
  • マークサンズ製薬部門、英国MHRAからシアノコバラミン50 mgフィルムコーティング錠の販売認可を取得
  • ルパンがシアノコバラミン鼻スプレーのジェネリック版を米国FDAから承認
  • EUROAPI、フランスでビタミンB12のより効率的で持続可能な生産プロセスに4,000万ユーロを投資
• 戦略分析と提言

企業一覧

• Adisseo Group
• Archer Daniels Midland Company
• BASF SE
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb
• Daiicho Sankyo Company
• Dr. Reddy's Laboratories Ltd.
• Eli Lilly and Company
• Endo International plc
• EUROAPI
• Eurofins Scientific Limited
• F. Hoffmann-La Roche Ltd
• Farbest-Tallman Foods Corporation
• Glanbia plc
• Golden Biotechnology Corp.
• Jamieson Laboratories Ltd.
• Koninklijke DSM N.V.
• Lonza Group
• Merck KGaA
• Pfizer Inc.
• Pharmavite LLC
• Rabar Pty. Ltd.
• SANOFI WINTHROP INDUSTRIE
• SternVitamin GmbH & Co. K.G.
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. CYANOCOBALAMIN MARKET RESEARCH PROCESS
• FIGURE 2. CYANOCOBALAMIN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CYANOCOBALAMIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES CYANOCOBALAMIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES CYANOCOBALAMIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. CYANOCOBALAMIN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. CYANOCOBALAMIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CYANOCOBALAMIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CYANOCOBALAMIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CYANOCOBALAMIN MARKET DYNAMICS
• TABLE 7. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY NASAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CYANOCOBALAMIN MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 23. CANADA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES CYANOCOBALAMIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. CHINA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. INDIA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA CYANOCOBALAMIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. ITALY CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. POLAND CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. QATAR CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM CYANOCOBALAMIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM CYANOCOBALAMIN MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 101. CYANOCOBALAMIN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. CYANOCOBALAMIN MARKET, FPNV POSITIONING MATRIX, 2023

The Cyanocobalamin Market was valued at USD 358.26 million in 2023, expected to reach USD 379.29 million in 2024, and is projected to grow at a CAGR of 6.12%, to USD 543.13 million by 2030.

Cyanocobalamin, a synthetic form of Vitamin B12, plays a critical role in various metabolic processes, including DNA synthesis and red blood cell formation. As a key player in the pharmaceutical industry, its necessity is driven by the increasing prevalence of vitamin B12 deficiencies, especially among vegetarians, the elderly, and those with absorption disorders. Its applications span across dietary supplements, fortified foods, and injectable medications for treating anemia and neurological disorders. The end-use scope extends to healthcare providers, pharmaceutical companies, and food and beverage industries. Market growth is significantly influenced by rising health awareness and dietary trends that prioritize nutrient-rich diets. Additionally, the expanding geriatric population and heightened research into neurodegenerative diseases are fueling demand. Emerging markets in Asia-Pacific and Latin America present promising opportunities due to improving healthcare infrastructures and growing nutritional awareness. However, market expansion faces challenges such as regulatory hurdles, especially concerning injectable forms, and competition from naturally-sourced or other synthetic B12 supplements. Price fluctuations due to raw material costs also pose risks. To capitalize on these opportunities, businesses should invest in research focused on improving bioavailability and exploring novel delivery mechanisms, such as sustained-release formulations or oral strips, to enhance consumer convenience. Emphasizing sustainable and clean-label production processes could cater to eco-conscious consumers and strengthen brand positioning. The current market is moderately competitive, characterized by product differentiation and innovation. By strategically focusing on unmet consumer needs and harnessing advancements in biotechnology, companies can unlock further growth. Additionally, forming strategic alliances with healthcare providers and leveraging digital platforms for direct consumer engagement can drive market penetration. Overall, the scope of innovation is vast, demanding a keen understanding of consumer preferences and regulatory landscapes to navigate this evolving market successfully.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cyanocobalamin Market

The Cyanocobalamin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising aging population and an increase in vitamin B12 deficiency cases worldwide
  • Growing adoption of plant-based diets globally
  • Increasing demand for functional foods and dietary supplements
• Market Restraints
  • Strict regulatory standards for approval with a shift towards natural and organic food sources of vitamin B12
• Market Opportunities
  • Technological advancements in drug delivery systems
  • Developing formulations with added benefits
• Market Challenges
  • Potential side effects and interactions with medication

Porter's Five Forces: A Strategic Tool for Navigating the Cyanocobalamin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cyanocobalamin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cyanocobalamin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cyanocobalamin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cyanocobalamin Market

A detailed market share analysis in the Cyanocobalamin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cyanocobalamin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cyanocobalamin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cyanocobalamin Market

A strategic analysis of the Cyanocobalamin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cyanocobalamin Market, highlighting leading vendors and their innovative profiles. These include Adisseo Group, Archer Daniels Midland Company, BASF SE, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb, Daiicho Sankyo Company, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Endo International plc, EUROAPI, Eurofins Scientific Limited, F. Hoffmann-La Roche Ltd, Farbest-Tallman Foods Corporation, Glanbia plc, Golden Biotechnology Corp., Jamieson Laboratories Ltd., Koninklijke DSM N.V., Lonza Group, Merck KGaA, Pfizer Inc., Pharmavite LLC, Rabar Pty. Ltd., SANOFI WINTHROP INDUSTRIE, SternVitamin GmbH & Co. K.G., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Cyanocobalamin Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Route of Administration, market is studied across Injectable Formulations, Nasal Formulations, and Oral Formulations.
• Based on End-use, market is studied across Animal Feed, Food & Beverages, and Healthcare.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising aging population and an increase in vitamin B12 deficiency cases worldwide
    • 5.1.1.2. Growing adoption of plant-based diets globally
    • 5.1.1.3. Increasing demand for functional foods and dietary supplements
  • 5.1.2. Restraints
    • 5.1.2.1. Strict regulatory standards for approval with a shift towards natural and organic food sources of vitamin B12
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in drug delivery systems
    • 5.1.3.2. Developing formulations with added benefits
  • 5.1.4. Challenges
    • 5.1.4.1. Potential side effects and interactions with medication
• 5.2. Market Segmentation Analysis
  • 5.2.1. Route of Administration: Increasing preference for oral formulations of cyanocobalamin for patients with mild vitamin B12 deficiency
  • 5.2.2. End-use: Expanding usage of cyanocobalamin in healthcare sector for preventing and treating vitamin B12 deficiencies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cyanocobalamin Market, by Route of Administration

• 6.1. Introduction
• 6.2. Injectable Formulations
• 6.3. Nasal Formulations
• 6.4. Oral Formulations

7. Cyanocobalamin Market, by End-use

• 7.1. Introduction
• 7.2. Animal Feed
• 7.3. Food & Beverages
• 7.4. Healthcare

8. Americas Cyanocobalamin Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cyanocobalamin Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cyanocobalamin Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Marksans Pharma Arm Gets Marketing Authorisation For Cyanocobalamin 50 mg Film Coated Tablets From UK MHRA
  • 11.3.2. Lupin gets USFDA approval for generic version of Cyanocobalamin nasal spray
  • 11.3.3. EUROAPI to invest EUR 40 million for a more efficient and sustainable production process of Vitamin B12 in France
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Adisseo Group
• 2. Archer Daniels Midland Company
• 3. BASF SE
• 4. Boehringer Ingelheim International GmbH
• 5. Bristol-Myers Squibb
• 6. Daiicho Sankyo Company
• 7. Dr. Reddy's Laboratories Ltd.
• 8. Eli Lilly and Company
• 9. Endo International plc
• 10. EUROAPI
• 11. Eurofins Scientific Limited
• 12. F. Hoffmann-La Roche Ltd
• 13. Farbest-Tallman Foods Corporation
• 14. Glanbia plc
• 15. Golden Biotechnology Corp.
• 16. Jamieson Laboratories Ltd.
• 17. Koninklijke DSM N.V.
• 18. Lonza Group
• 19. Merck KGaA
• 20. Pfizer Inc.
• 21. Pharmavite LLC
• 22. Rabar Pty. Ltd.
• 23. SANOFI WINTHROP INDUSTRIE
• 24. SternVitamin GmbH & Co. K.G.
• 25. Viatris Inc.